Description
EMWIN-10 is an oral antidiabetic tablet that contains 10mg of Empagliflozin. It is used to manage Type-2 Diabetes Mellitus along with proper diet, exercise, and medical advice. Empagliflozin belongs to the SGLT2 inhibitor group of medicines. It works through the kidneys by helping the body to remove extra sugar through urine, which helps lower blood sugar levels.
Arrowin Pharmaceuticals offers EMWIN-10 under its Medace-Cardiac Diabetic division.
Key Features of EMWIN-10:
- It contains empagliflozin in an easy-to-take tablet form.
- Belongs to the SGLT2 inhibitor group of antidiabetic medicines.
- This tablet is used to help manage blood sugar levels inType-2 diabetes.
- Available in 10 x10 Alu-Alu packaging
- The EMWIN range also includes EMWIN-25.
How Does Empagliflozin 10mg Tablet Work?
Empagliflozin 10mg tablet mainly works through the kidneys to help control blood sugar. Normally, the kidneys take back some of the sugar from the urine and return it to the blood. Empagliflozin reduces the sugar reabsorption, allowing more glucose ot leave the body through urine. This Helps to:
- Lower blood sugar levels
- Remove extra sugar through urine
- Reduce the amount of glucose reabsorbed by the kidneys
- Support better blood-sugar control
Empagliflozin Tablets for Cardiac Diabetic PCD Pharma Franchise – Arrowin Pharmaceuticals
Arrowin Pharmaceuticals offers a dedicated Cardiac Diabetic PCD Pharma Franchise range, including Empagliflozin 10mg Tablets, under their brand name EMWIN-10 for pharma professionals, distributors, and entrepreneurs. The company’s portfolio includes products from categories such as antidiabetic medicines, antihypertensives, lipid-lowering medicines, antiplatelets, cardiac-care products, and nutraceuticals.
For PCD franchise partners, this anti-diabetic tablet can be added to a broader diabetes and cardiovascular product portfolio, depending on market requirements, product availability, and applicable business terms.
Why Add EMWIN-10 to Your Portfolio?
- Contains Empagliflozin for Type 2 Diabetes management.
- Listed under Arrowin’s Medace – Cardiac Diabetic range.
- The EMWIN range includes EMWIN-10 and EMWIN-25.
- Can complement other suitable antidiabetic products.
- Suitable for franchise partners, distributors, wholesalers, stockists, and pharma entrepreneurs.
Benefits of EMWIN-10
- Helps support blood sugar control in Type 2 Diabetes.
- Helps the body remove extra glucose through urine.
- Contains Empagliflozin 10 mg in a convenient tablet form.
- Can be used as part of a doctor-guided diabetes treatment plan.
- May be used with other diabetes medicines when prescribed by a doctor.
- Provides a single-molecule antidiabetic option.
- Can be included in a Cardiac Diabetic PCD Pharma portfolio.
